| |
Latest 10 SEC filings (by transaction date) for TRVN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,835 | $0.610 |
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 25,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -7,123 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 370,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,616 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 185,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Demitrack Mark | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,593 | $0.610 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TRVN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,835 | $0.610 |
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 25,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Drake Patricia M. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -7,123 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Bourdow Carrie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 370,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,616 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Shin Barry | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 185,000 | $0.610 |
Dec 15/23 | Dec 14/23 | Demitrack Mark | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,593 | $0.610 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |